# Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

Source: https://onco.cc/trials/nct06933329/  
OnCo record `nct06933329` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Zelenectide pevedotin in non-small-cell lung cancer and small-cell lung cancer, run by BicycleTx Limited, active and no longer recruiting.

## Summary

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer is a phase 2 interventional study registered as NCT06933329 by BicycleTx Limited, with 73 participants planned, started 2025-07-18 and due to reach its primary completion in 2028-08-31. Interventions recorded: Zelenectide pevedotin. Conditions listed: Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06933329
- Phase: 2
- Setting: Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
- Sponsor: BicycleTx Limited
- Enrolled: 73

## Sources

- ClinicalTrials.gov NCT06933329: https://clinicaltrials.gov/study/NCT06933329

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [Zelenectide pevedotin](https://onco.cc/drugs/zelenectide-pevedotin/)
- companies: [Bicycle Therapeutics](https://onco.cc/companies/bicycle-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/nct06933329.json